Skip over global navigation links
U.S. Department of Health and Human Services
  • HHS advances development of Ebola vaccine

    Studies will prepare vaccine candidate for clinical trials

    Under a one-year contract with Profectus BioSciences Inc., headquartered in Baltimore, BARDA will provide approximately $5.8 million in funding, in addition to subject matter expertise and technical assistance, to further develop an experimental Ebola vaccine.


    Arrows pointing to 

a vaccine vial
Retrieving Data
Folder icon
  • This page last reviewed: November 07, 2014